Article

TAS2R38-Linked MGAM Expression in Alzheimer’s Disease: A Novel Target for Precision Drug Repurposing

2025-09-12

Abstract excerpt

<h4>Objective</h4> TAS2R38 is a taste receptor implicated in innate immunity. Identifying its genetic connection with Alzheimer’s disease (AD) could aid in developing new drugs or repurposing existing ones for treatment. <h4>Methods</h4> We examined the relationship between TAS2R38 taster variants and AD risk using linear mixed-effects models, utilizing data from the Alzheimer’s Disease Neuroimaging Initiative (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 34605c45-9fda-597d-9f36-f5413b4f59f5
DOI: 10.1101/2025.09.09.25334938

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

TAS2R38-Linked MGAM Expression in Alzheimer’s Disease: A Novel Target for Precision Drug RepurposingDOI 10.1101/2025.09.09.25334938Read

Genomic Study of Taste Perception Genes in African Americans Reveals SNPs Linked to Alzheimer’s DiseaseSemantic proximity Read

Genomic study of taste perception genes in African Americans reveals SNPs linked to Alzheimer's disease.Semantic proximity Read

TAS2R38 Polymorphism and Bitter Taste Perception: Implications for Satmaya and Upashaya-Anupshaya Beyond PrakritiSemantic proximity Read

Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s diseaseSemantic proximity Read

The tissue-specific effects of glucose-lowering drug targets on aging mediated through DNA methylation: a multi-omics genetic studySemantic proximity Read

The tissue-specific effects of glucose-lowering drug targets on aging mediated through DNA methylation: a multi-omics genetic studySemantic proximity Read

Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology.Semantic proximity Read

Brain Multi-Omic Subtypes of Neuroticism reveal molecular signatures linked to Alzheimer’s DiseaseSemantic proximity Read

Multi-omics analysis reveals aspirin is associated with reduced risk of Alzheimer’s diseaseSemantic proximity Read

Oral Blarcamesine Phase IIb/III Trial Confirms Identified Precision Medicine Patient Population – Significant Broad Clinical and Quality of Life Improvements for Early Alzheimer’s Disease PatientsSemantic proximity Read

Guanosine monophosphate reductase 1 is a potential therapeutic target for Alzheimer’s diseaseSemantic proximity Read

Genome-wide Meta-analysis on the Sense of Smell Among US Older Adults.Semantic proximity Read